Decrease in brain serotonin 2 receptor binding in patients with major depression following desipramine treatment: a...

Area of Science:

• Neuroscience
• Psychiatry
• Pharmacology

Background:

• Neuroreceptor changes underlying antidepressant efficacy are not fully understood.
• Preclinical studies suggest long-term antidepressant use down-regulates serotonin 2 (5-HT2) receptors.
• It remains unclear if these neuroreceptor changes occur in depressed patients undergoing treatment.

Purpose of the Study:

• To investigate the impact of desipramine hydrochloride treatment on brain 5-HT2 receptors in patients with major depression.
• To utilize positron emission tomography (PET) and fluorine-18 (18F)-labeled setoperone for assessing receptor binding.

Main Methods:

• Eleven patients meeting DSM-IV criteria for major depression were recruited.
• Ten patients received PET scans before and after 3-4 weeks of desipramine treatment.
• Hamilton Depression Rating Scale (HDRS) was used to assess treatment response.

Main Results:

• Eight out of ten patients showed a significant clinical response to desipramine ( >50% HDRS decrease).
• Desipramine treatment led to a significant decrease in 5-HT2 receptor binding in cortical regions (frontal, temporal, parietal, occipital).
• The reduction in 5-HT2 receptor binding was bilateral, most pronounced in the frontal cortex.

Conclusions:

• Depressed patients exhibited a significant reduction in available brain 5-HT2 receptors after desipramine treatment.
• It is uncertain whether this 5-HT2 receptor change is a direct result of clinical improvement or an independent effect of desipramine.
• Further research is needed to elucidate the precise relationship between 5-HT2 receptor modulation and antidepressant therapeutic effects.